1Hirsh J, Fuster V,Ansell J,et al. American Heart As-sociation/ American College of Cardiology FoundationGuide to warfarin therapy [J]. Circulation,2003? 107(12):1692-1711.
2Wysowski D K,Nourjah P,Swartz L. Bleeding compli-cations with warfarin use: a prevalent adverse effect re-sulting in regulatory action[J]. Arch Intern Med, 2007,167(13) :1414-1419.
3Esmerio F G, Souza E N,Leiria T L,et al. Constant useof oral anticoagulants : implications in the control of theiradequate levels[J]. Arq Bras Cardiol, 2009 ?93(5): 549-554.
4Morisky D E,Ang A,Krouse-Wood M,et al. Predictivevalidity of a medication adherence measure in an outpa-tient setting[J]. J Clin Hypertens (Greenwich),2008,10(5):348-354.
5Briggs A L,Jackson T R,Bruce S,et al. The develop-ment and performance validation of a tool to assess pa-tient anticoagulation knowledge [J]. Res Social AdmPharm,2005,1(1) :40-59.
6Van Damme S,Van Deyk K,Budts W,et al. Patient know-ledge of and adherence to oral anticoagulation therapy aftermechanical heart-valve replacement for congenital or acquiredvalve defectsQ], Heart Lung,2011,40(2) : 139-146.
7Morisky D E, Green L W,Levine D M. Concurrent and pre-dictive validity of a self-reported measure of medication ad-herence[J]. Med Care,1986,24(l) :67-74.
8Kim J H,Kim G S,Kim E J, et al. Factors affecting medi-cation adherence and anticoagulation control in Korean pa-tients taking warfarin [J]. J Cardiovasc Nurs> 2011, 26 (6):466-474.
9Kimmel S E,Chen Z,Price M,et al. The influence of pa-tient adherence on anticoagulation control with warfarin : re-sults from the international Normalized Ratio Adherence andGenetics (IN-RANGE) study[J]. Arch Intern Med,2007,167(3);229-235.
10Wroe A L. Intentional and unintentional nonadherence : astudy of decision making[J]. J Behav Med,2002,25(4) :355--372.
